Takami Sato

Department of Medical Oncology, Thomas Jefferson University

Affiliated withThomas Jefferson University

Research Area

Cancer Research

Biography

Takami Sato has not added Biography.
If you are Takami Sato and would like to personalize this page please email our Author Liaison for assistance.

JoVE Journal Publications

Article Total : 1	Year
Publication title	2019

Other Publications

Article	Year
Locoregional immuno(bio)therapy for liver metastases. Seminars in oncology\| PubMed ID: 11951214	2002
Effect of the dose and composition of an autologous hapten-modified melanoma vaccine on the development of delayed-type hypersensitivity responses. Cancer immunology, immunotherapy : CII\| PubMed ID: 12111120	2002
TCR rearrangement in lymphocytes infiltrating melanoma metastases after administration of autologous dinitrophenyl-modified vaccine. Journal of immunology (Baltimore, Md. : 1950)\| PubMed ID: 12218163	2002
Combination of monocyte-derived dendritic cells and activated T cells which express CD40 ligand: a new approach to cancer immunotherapy. Cancer immunology, immunotherapy : CII\| PubMed ID: 13680192	2004
Immunopharmacologic analysis of an autologous, hapten-modified human melanoma vaccine. Journal of clinical oncology : official journal of the American Society of Clinical Oncology\| PubMed ID: 14691123	2004
Chemoembolization of the hepatic artery with BCNU for metastatic uveal melanoma: results of a phase II study. Melanoma research\| PubMed ID: 16034309	2005
A pilot study of low-dose thalidomide and interferon alpha-2b in patients with metastatic melanoma who failed prior treatment. Melanoma research\| PubMed ID: 17625452	2007
The biology and management of uveal melanoma. Current oncology reports\| PubMed ID: 18706273	2008
Locoregional treatment of malignant hepatic tumors with biologic response modifiers. Surgical oncology clinics of North America\| PubMed ID: 18722927	2008
Immunoembolization of malignant liver tumors, including uveal melanoma, using granulocyte-macrophage colony-stimulating factor. Journal of clinical oncology : official journal of the American Society of Clinical Oncology\| PubMed ID: 18838710	2008
Human interleukin 10 receptor 1/IgG1-Fc fusion proteins: immunoadhesins for human IL-10 with therapeutic potential. Cancer immunology, immunotherapy : CII\| PubMed ID: 19142637	2009
Expression of indoleamine 2,3-dioxygenase in metastatic malignant melanoma recruits regulatory T cells to avoid immune detection and affects survival. Cell cycle (Georgetown, Tex.)\| PubMed ID: 19448397	2009
High-dose immunoembolization: survival benefit in patients with hepatic metastases from uveal melanoma. Radiology\| PubMed ID: 19561263	2009
Locoregional management of hepatic metastasis from primary uveal melanoma. Seminars in oncology\| PubMed ID: 20494705	2010
Conjunctival melanoma: bladder and upper urinary tract metastases. Journal of clinical oncology : official journal of the American Society of Clinical Oncology\| PubMed ID: 21189399	2011
Radioembolization as salvage therapy for hepatic metastasis of uveal melanoma: a single-institution experience. AJR. American journal of roentgenology\| PubMed ID: 21257902	2011
Tumor-derived interleukin-10 as a prognostic factor in stage III patients undergoing adjuvant treatment with an autologous melanoma cell vaccine. Cancer immunology, immunotherapy : CII\| PubMed ID: 21519827	2011
Side-branch embolization before 90Y radioembolization: rate of recanalization and new collateral development. AJR. American journal of roentgenology\| PubMed ID: 21700981	2011
Toxicities after radioembolization with yttrium-90 SIR-spheres: incidence and contributing risk factors at a single center. Journal of vascular and interventional radiology : JVIR\| PubMed ID: 21764600	2011
Moxifloxacin prophylaxis for chemoembolization or embolization in patients with previous biliary interventions: a pilot study. AJR. American journal of roentgenology\| PubMed ID: 21785063	2011
Lymph node ratio is an important and independent prognostic factor for patients with stage III melanoma. Journal of surgical oncology\| PubMed ID: 21815149	2012
Interleukin 6 mediates production of interleukin 10 in metastatic melanoma. Cancer immunology, immunotherapy : CII\| PubMed ID: 21853302	2012
Interleukin 10 in the tumor microenvironment: a target for anticancer immunotherapy. Immunologic research\| PubMed ID: 22139852	2011
Somatostatin receptor scintigraphy in patients with metastatic uveal melanoma. Melanoma research\| PubMed ID: 23164993	2013
Early arterial stasis during resin-based yttrium-90 radioembolization: incidence and preliminary outcomes. HPB : the official journal of the International Hepato Pancreato Biliary Association\| PubMed ID: 23782387	2013
The potential role of sunitinib targeting melanomas. Expert opinion on investigational drugs\| PubMed ID: 24050392	2013
Expression of insulin-like growth factor-1 receptor in metastatic uveal melanoma and implications for potential autocrine and paracrine tumor cell growth. Pigment cell & melanoma research\| PubMed ID: 24354797	2014
High-dose vincristine sulfate liposome injection (Marqibo) Is not associated with clinically meaningful hematologic toxicity. Clinical lymphoma, myeloma & leukemia\| PubMed ID: 24417913	2014
Transhepatic therapies for metastatic uveal melanoma. Seminars in interventional radiology\| PubMed ID: 24436516	2013
Yttrium-90 Microsphere Brachytherapy for Liver Metastases From Uveal Melanoma: Clinical Outcomes and the Predictive Value of Fluorodeoxyglucose Positron Emission Tomography. American journal of clinical oncology\| PubMed ID: 24441583	2016
Integrin receptors on tumor cells facilitate NK cell-mediated antibody-dependent cytotoxicity. European journal of immunology\| PubMed ID: 24810893	2014
Effect of selumetinib vs chemotherapy on progression-free survival in uveal melanoma: a randomized clinical trial. JAMA\| PubMed ID: 24938562	2014
Biology of advanced uveal melanoma and next steps for clinical therapeutics. Pigment cell & melanoma research\| PubMed ID: 25113308	2015
Tumor necrosis factor-α blockade and development of uveal melanoma: expected adverse effect or just coincidence? Mayo Clinic proceedings\| PubMed ID: 25444483	2014
Double-blinded, randomized phase II study using embolization with or without granulocyte-macrophage colony-stimulating factor in uveal melanoma with hepatic metastases. Journal of vascular and interventional radiology : JVIR\| PubMed ID: 25678394	2015
Uveal Melanoma Metastatic to the Liver: Chemoembolization With 1,3-Bis-(2-Chloroethyl)-1-Nitrosourea. AJR. American journal of roentgenology\| PubMed ID: 25905562	2015
Paracrine Effect of NRG1 and HGF Drives Resistance to MEK Inhibitors in Metastatic Uveal Melanoma. Cancer research\| PubMed ID: 25952648	2015
Successes and setbacks of early investigational drugs for melanoma. Expert opinion on investigational drugs\| PubMed ID: 26068553	2015
Establishment and Characterization of Orthotopic Mouse Models for Human Uveal Melanoma Hepatic Colonization. The American journal of pathology\| PubMed ID: 26613897	2016
Autologous melanoma cell vaccine using monocyte-derived dendritic cells (NBS20/eltrapuldencel-T). Future oncology (London, England)\| PubMed ID: 26837440	2016
Arterial Blood, Rather Than Venous Blood, is a Better Source for Circulating Melanoma Cells. EBioMedicine\| PubMed ID: 26870807	2015
Immune Check Point Inhibitors Combination in Melanoma: Worth the Toxicity? Reviews on recent clinical trials\| PubMed ID: 27028970	2016
Relationship between physician-adjudicated adverse events and patient-reported health-related quality of life in a phase II clinical trial (NCT01143402) of patients with metastatic uveal mel... Journal of cancer research and clinical oncology\| PubMed ID: 27921276	2017
Ladarixin, a dual CXCR1/2 inhibitor, attenuates experimental melanomas harboring different molecular defects by affecting malignant cells and tumor microenvironment. Oncotarget\| PubMed ID: 28129639	2017
Co-targeting HGF/cMET Signaling with MEK Inhibitors in Metastatic Uveal Melanoma. Molecular cancer therapeutics\| PubMed ID: 28138035	2017
Guanylate cyclase C as a target for prevention, detection, and therapy in colorectal cancer. Expert review of clinical pharmacology\| PubMed ID: 28162021	2017
Image-Guided Transarterial Chemoembolization With Drug-Eluting Beads Loaded with Doxorubicin (DEBDOX) for Unresectable Hepatic Metastases from Melanoma: Technique and Outcomes. Cardiovascular and interventional radiology\| PubMed ID: 28508253	2017
Establishment of an orthotopic patient-derived xenograft mouse model using uveal melanoma hepatic metastasis. Journal of translational medicine\| PubMed ID: 28645290	2017
Health-related quality of life during trans-arterial chemoembolization with drug-eluting beads loaded with doxorubicin (DEBDOX) for unresectable hepatic metastases from ocular melanoma. American journal of surgery\| PubMed ID: 28754534	2017
Phase 1 Study of Ipilimumab Combined With Whole Brain Radiation Therapy or Radiosurgery for Melanoma Patients With Brain Metastases. International journal of radiation oncology, biology, physics\| PubMed ID: 28816150	2017
Adjuvant Sunitinib in High-Risk Patients with Uveal Melanoma: Comparison with Institutional Controls. Ophthalmology\| PubMed ID: 28935400	2018
A Comprehensive Patient-Derived Xenograft Collection Representing the Heterogeneity of Melanoma. Cell reports\| PubMed ID: 29141225	2017
PD-L1 expression in tumor metastasis is different between uveal melanoma and cutaneous melanoma. Immunotherapy\| PubMed ID: 29185395	2017
CHECKPOINT INHIBITOR IMMUNE THERAPY: Systemic Indications and Ophthalmic Side Effects. Retina (Philadelphia, Pa.)\| PubMed ID: 29689030	2018
Effects of Oncogenic Gα and Gα Inhibition by FR900359 in Uveal Melanoma. Molecular cancer research : MCR\| PubMed ID: 30567972	2019
Stromal fibroblast growth factor 2 reduces the efficacy of bromodomain inhibitors in uveal melanoma. EMBO molecular medicine\| PubMed ID: 30610113	2019
First-in-Human Phase I Study of Merestinib, an Oral Multikinase Inhibitor, in Patients with Advanced Cancer. The oncologist\| PubMed ID: 30833489	2019
Split tolerance permits safe Ad5-GUCY2C-PADRE vaccine-induced T-cell responses in colon cancer patients. Journal for immunotherapy of cancer\| PubMed ID: 31010434	2019
IsomiRs and tRNA-derived fragments are associated with metastasis and patient survival in uveal melanoma. Pigment cell & melanoma research\| PubMed ID: 31283110	2019
A Prospective Phase II Trial of Radioembolization for Treatment of Uveal Melanoma Hepatic Metastasis. Radiology\| PubMed ID: 31453767	2019